You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paclitaxel，Neoadjuvant chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Carcinoma, Neoadjuvant Therapy Trial (Toripalimab, Anlotinib HCl, Albumin paclitaxel)

Not yet recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Therapy
  • (no location specified)
Aug 16, 2023

Albumin Binding Paclitaxel Compared With Common Paclitaxel in

Recruiting
  • Breast Cancer
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Nov 24, 2022

Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)

Recruiting
  • Esophageal Carcinoma
  • Neoadjuvant Immunotherapy
  • PD-1 blockade
  • +2 more
  • Beijing, Beijing, China
    Qin li
Mar 8, 2023

Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)

Recruiting
  • Locally Advanced Breast Cancer
  • Chemotherapy Effect
  • inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
  • Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Feb 28, 2023

Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Beijing, Beijing, China
    Beijing Tongren Hospital
Oct 26, 2023

Locally Advanced Vulvar Carcinoma, Squamous Cell Carcinoma of the Vulva Trial (Paclitaxel and Carboplatin, Chemoradiation)

Not yet recruiting
  • Locally Advanced Vulvar Carcinoma
  • Squamous Cell Carcinoma of the Vulva
  • Paclitaxel and Carboplatin
  • Chemoradiation
  • (no location specified)
Jun 6, 2023

Locally Advanced, Squamous Cell Carcinoma of the Vulva Trial in Amsterdam (Paclitaxel and Carboplatin)

Recruiting
  • Locally Advanced, Squamous Cell Carcinoma of the Vulva
  • Paclitaxel and Carboplatin
  • Amsterdam, Netherlands
    NKI-AVL
Oct 18, 2022

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Oral Squamous Cell Carcinoma Trial (Tislelizumab, Albumin paclitaxel, Cisplatin)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • (no location specified)
May 7, 2023

Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

Recruiting
  • Neoadjuvent
  • +3 more
  • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
  • Xi'an, Shaanxi, China
  • +2 more
Aug 17, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

Breast Cancer Trial in Shantou (dose-dense nab-paclitaxel followed by EC)

Recruiting
  • Breast Cancer
  • dose-dense nab-paclitaxel followed by EC
  • Shantou, Guangdong, China
    Shantou Central Hospital
Feb 4, 2023

Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

Recruiting
  • Esophagus Cancer
  • Xiamen, Fujian, China
    ShanghaiZhongshan
Apr 8, 2023

Neoadjuvant Chemotherapy Compared With Surgery for Esophageal

Completed
  • Esophagus Cancer
  • Paclitaxel- and platinum-based chemotherapy
  • Zhengzhou, Henan, China
    Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
Oct 5, 2022

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Penpulimab injection
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
Oct 7, 2023

Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

Not yet recruiting
  • Neoplasms
  • +2 more
  • Nivolumab Injection [Opdivo]
  • (no location specified)
Jul 19, 2023

Resectable Biliary Tract Cancer Trial in Tianjin (Cisplatin, Gemcitabine, Nab-paclitaxel)

Recruiting
  • Resectable Biliary Tract Cancer
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Nov 30, 2022

Breast Cancer, Chemo Effect Trial (Nab paclitaxel, Docetaxel)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • (no location specified)
Feb 11, 2022

NSCLC, Stage III Trial in Beijing (Tislelizumab, Pemetrexed (Nonsquamous NSCLC) or Paclitaxel/Nab-paclitaxel(Squamous NSCLC),

Recruiting
  • NSCLC, Stage III
  • Beijing, Beijing, China
    Beijing Tsinghua Chang Gung Hospital
Nov 4, 2022

Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 24, 2023

Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 23, 2022

Triple Negative Breast Cancer, Breast Tumors Trial in Fayetteville, Little Rock (P10s-PADRE with MONTANIDE™ ISA 51 VG +

Active, not recruiting
  • Triple Negative Breast Cancer
  • Breast Neoplasms
  • P10s-PADRE with MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Paclitaxel
  • Doxorubicin + Cyclophosphamide + Paclitaxel
  • Fayetteville, Arkansas
  • +1 more
Aug 18, 2022

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab paclitaxel
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Pancreatic Cancer Trial in Shanghai (Neoadjuvant gemcitabine plus nab-paclitaxel, Neoadjuvant gemcitabine plus nab-paclitaxel

Recruiting
  • Pancreatic Cancer
  • Neoadjuvant gemcitabine plus nab-paclitaxel
  • +2 more
  • Shanghai, Shanghai, China
    Changhai Hospital
Mar 8, 2022

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai chest hospital
Sep 24, 2023